What 4 Analyst Ratings Have To Say About Agios Pharmaceuticals

Loading...
Loading...

Within the last quarter, Agios Pharmaceuticals AGIO has observed the following analyst ratings:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 3 0 1 0 0
Last 30D 0 0 1 0 0
1M Ago 2 0 0 0 0
2M Ago 0 0 0 0 0
3M Ago 1 0 0 0 0

In the last 3 months, 4 analysts have offered 12-month price targets for Agios Pharmaceuticals. The company has an average price target of $56.5 with a high of $98.00 and a low of $30.00.

Below is a summary of how these 4 analysts rated Agios Pharmaceuticals over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

This current average represents a 5.31% increase from the previous average price target of $59.67.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

What Are Analyst Ratings?

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: Analyst RatingsBZI-AAR
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...